|
Rezolute Inc (NASDAQ: RZLT) |
|
Rezolute Inc
RZLT's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Rezolute Inc 's sales fell
in I. Quarter 2024 from the same quarter a year ago.
Major Pharmaceutical Preparations industry recorded
growth of revenues by 9.75 %
Rezolute Inc net loss increased from $-15 millions, to $-15 millions in I. Quarter 2024,
• More on RZLT's Growth
|
|
Rezolute Inc realized a net loss in trailing twelve months.
Company is currently trading with Price to Cash flow multiple of 140.34 in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.49.
• More on RZLT's Valuation
|
|
|
|
|
Rezolute Inc realized net loss in trailing twelve months.
Company is currently trading with Price to Cash flow multiple of 140.34 in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.49.
Rezolute Inc Price to Book Ratio is at 2.99 lower than Industry Avg. of 83.13. and higher than S&P 500 Avg. of 0.02
• More on RZLT's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com